S.Amdt. 2117
What it does: Adds SEC. 11__. PRACTITIONER EDUCATION at the end of title XIWhat it changes
1 change to S. 3187 · shown in the bill's text
Adds SEC. 11__. PRACTITIONER EDUCATION at the end of title XI
Adds a sectionIn S. 3187 · Placed on Calendar Senate
"(b) Financial Interest.--In this section, the term 'financial interest' means a financial interest under section 208(a) of title 18, United States Code.".
Inserted: SEC. 11__. PRACTITIONER EDUCATION.
Inserted: (a) Education Requirements.--
Inserted: (1) Registration consideration.--Section 303(f) of the Controlled Substances Act (21 U.S.C. 823(f)) is amended by inserting after paragraph (5) the following:
Inserted: "(6) The applicant's compliance with the training requirements described in subsection (g)(3) during any previous period in which the applicant has been subject to such training requirements.".
Inserted: (2) Training requirements.--Section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) is amended by adding at the end the following:
Inserted: "(3)(A) To be registered to prescribe or otherwise dispense methadone or other opioids, a practitioner described in paragraph (1) shall comply with the 16-hour training requirement of subparagraph (B) at least once during each 3-year period.
Inserted: "(B) The training requirement of this subparagraph is that the practitioner has completed not less than 16 hours of training (through classroom situations, seminars at professional society meetings, electronic communications, or otherwise) with respect to--
Inserted: "(i) the treatment and management of opioid-dependent patients;
Inserted: "(ii) pain management treatment guidelines; and
Inserted: "(iii) early detection of opioid addiction, including through such methods as Screening, Brief Intervention, and Referral to Treatment (SBIRT), that is provided by relevant professional societies, as determined by the Secretary.".
Inserted: (b) Requirements for Participation in Opioid Treatment Programs.--Effective July 1, 2013, a physician practicing in an opioid treatment program shall comply with the requirements of section 303(g)(3) of the Controlled Substances Act (as added by subsection (a)) with respect to required minimum training at least once during each 3-year period.
Inserted: (c) Definition.--In this section, the term "opioid treatment program" has the meaning given such term in section 8.2 of title 42, Code of Federal Regulations (or any successor regulation).
Show 1 more inserted paragraphShow less
Inserted: (d) Funding.--The Drug Enforcement Administration shall fund the enforcement of the requirements specified in section 303(g)(3) of the Controlled Substances Act (as added by subsection (a)) through the use of a portion of the licensing fees paid by controlled substance prescribers under the Controlled Substances Act (21 U.S.C. 801 et seq.).
Original wording
At the end of title XI, add the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 2117. Mr. ROCKEFELLER submitted an amendment intended to be proposed by him to the bill S. 3187, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes; which was ordered to lie on the table; as follows:
At the end of title XI, add the following:
SEC. 11__. PRACTITIONER EDUCATION.
(a) Education Requirements.--
(1) Registration consideration.--Section 303(f) of the Controlled Substances Act (21 U.S.C. 823(f)) is amended by inserting after paragraph (5) the following:
“(6) The applicant's compliance with the training requirements described in subsection (g)(3) during any previous period in which the applicant has been subject to such training requirements.”.
(2) Training requirements.--Section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) is amended by adding at the end the following:
“(3)(A) To be registered to prescribe or otherwise dispense methadone or other opioids, a practitioner described in paragraph (1) shall comply with the 16-hour training requirement of subparagraph (B) at least once during each 3-year period.
“(B) The training requirement of this subparagraph is that the practitioner has completed not less than 16 hours of training (through classroom situations, seminars at professional society meetings, electronic communications, or otherwise) with respect to--
“(i) the treatment and management of opioid-dependent patients;
“(ii) pain management treatment guidelines; and
“(iii) early detection of opioid addiction, including through such methods as Screening, Brief Intervention, and Referral to Treatment (SBIRT), that is provided by relevant professional societies, as determined by the Secretary.”.
(b) Requirements for Participation in Opioid Treatment Programs.--Effective July 1, 2013, a physician practicing in an opioid treatment program shall comply with the requirements of section 303(g)(3) of the Controlled Substances Act (as added by subsection (a)) with respect to required minimum training at least once during each 3-year period.
(c) Definition.--In this section, the term “opioid treatment program” has the meaning given such term in section 8.2 of title 42, Code of Federal Regulations (or any successor regulation).
(d) Funding.--The Drug Enforcement Administration shall fund the enforcement of the requirements specified in section 303(g)(3) of the Controlled Substances Act (as added by subsection (a)) through the use of a portion of the licensing fees paid by controlled substance prescribers under the Controlled Substances Act (21 U.S.C. 801 et seq.).
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment submitted
May 21, 2012